BidaskClub upgraded shares of Teladoc, Inc. (NYSE:TDOC) from a sell rating to a hold rating in a report issued on Wednesday.

Several other analysts have also recently commented on TDOC. Chardan Capital raised their price target on shares of Teladoc from $28.00 to $30.00 and gave the stock a buy rating in a report on Tuesday, May 9th. Robert W. Baird restated a buy rating and set a $28.00 price target on shares of Teladoc in a report on Tuesday, May 9th. Zacks Investment Research upgraded shares of Teladoc from a sell rating to a hold rating in a report on Thursday, May 11th. Craig Hallum cut shares of Teladoc from a buy rating to a hold rating and raised their price target for the stock from $28.00 to $32.00 in a report on Friday, May 12th. Finally, KeyCorp initiated coverage on shares of Teladoc in a report on Wednesday, May 17th. They set an overweight rating and a $37.00 price target for the company. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and nine have given a buy rating to the stock. The stock currently has an average rating of Buy and a consensus price target of $35.55.

Shares of Teladoc (NYSE:TDOC) traded up 3.94% during trading on Wednesday, reaching $33.00. 1,479,161 shares of the company traded hands. Teladoc has a 12 month low of $14.00 and a 12 month high of $36.90. The firm has a 50-day moving average price of $31.87 and a 200-day moving average price of $29.00. The firm’s market capitalization is $1.87 billion.

Teladoc (NYSE:TDOC) last posted its quarterly earnings results on Wednesday, August 2nd. The health services provider reported ($0.28) EPS for the quarter, missing the consensus estimate of ($0.26) by $0.02. The company had revenue of $44.60 million for the quarter, compared to analyst estimates of $44.39 million. Teladoc had a negative return on equity of 19.88% and a negative net margin of 47.75%. The business’s revenue for the quarter was up 68.3% compared to the same quarter last year. During the same quarter in the prior year, the business posted ($0.38) earnings per share. Equities research analysts anticipate that Teladoc will post ($1.44) EPS for the current year.

COPYRIGHT VIOLATION NOTICE: “Teladoc, Inc. (TDOC) Raised to Hold at BidaskClub” was originally posted by Daily Political and is the sole property of of Daily Political. If you are reading this piece of content on another publication, it was stolen and republished in violation of U.S. and international copyright law. The original version of this piece of content can be viewed at https://www.dailypolitical.com/2017/09/09/teladoc-inc-tdoc-raised-to-hold-at-bidaskclub.html.

In related news, insider Adam C. Vandervoort sold 53,806 shares of the firm’s stock in a transaction that occurred on Monday, August 7th. The shares were sold at an average price of $30.92, for a total transaction of $1,663,681.52. Following the transaction, the insider now owns 33,008 shares of the company’s stock, valued at $1,020,607.36. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. 4.47% of the stock is currently owned by company insiders.

Large investors have recently added to or reduced their stakes in the company. ETF Managers Group LLC bought a new position in shares of Teladoc in the second quarter valued at approximately $104,000. Bank of Montreal Can raised its position in shares of Teladoc by 214.2% in the second quarter. Bank of Montreal Can now owns 3,516 shares of the health services provider’s stock valued at $123,000 after purchasing an additional 2,397 shares during the period. Pacad Investment Ltd. bought a new position in shares of Teladoc in the second quarter valued at approximately $135,000. Fred Alger Management Inc. bought a new position in shares of Teladoc in the second quarter valued at approximately $139,000. Finally, Great West Life Assurance Co. Can bought a new position in shares of Teladoc in the first quarter valued at approximately $105,000.

Teladoc Company Profile

Teladoc, Inc is a telehealth company. The Company offers telehealth platform, delivering on-demand healthcare anytime, anywhere, through mobile devices, the Internet, video and phone. The Company’s solution connects its Members, with its over 3,000 board certified physicians and behavioral health professionals treating a range of conditions and cases from acute diagnoses, such as upper respiratory infection, urinary tract infection and sinusitis to dermatological conditions, anxiety and smoking cessation.

Analyst Recommendations for Teladoc (NYSE:TDOC)

Receive News & Ratings for Teladoc Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Inc. and related companies with MarketBeat.com's FREE daily email newsletter.